These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32922187)

  • 1. Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology.
    Hu S; Chen S; Li Z; Wang Y; Wang Y
    Int J Med Sci; 2020; 17(15):2240-2247. PubMed ID: 32922187
    [No Abstract]   [Full Text] [Related]  

  • 2. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
    He L; Shen K; He L; Chen Y; Tang Z
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
    Zeng T; Ling C; Liang Y
    Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Xu L; Huang F; Zhang Y; Niu W; Pang J; Li S; Li X
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(9):1319-1328. PubMed ID: 34658345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism and compatibility efficacy of Astragali Radix-Chuanxiong Rhizoma drug pair in treating ischemic stroke based on network regulation].
    Li ZH; Qi MZ; Huang HL; Su XH; Kong XY
    Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2326-2335. PubMed ID: 38812133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential immune-related therapeutic mechanisms of multiple traditional Chinese medicines on type 2 diabetic nephropathy based on bioinformatics, network pharmacology and molecular docking.
    Han M; Li J; Wu Y; Tang Z
    Int Immunopharmacol; 2024 May; 133():112044. PubMed ID: 38648716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and
    Han Y; Wei S; Liu C; Nie Y; Yuan S; Ma Y; Zhao Y; Zhang G
    Comb Chem High Throughput Screen; 2024; 27(14):2078-2089. PubMed ID: 37861047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis.
    Liu W; Yuan L; Che M; Hou S; Meng F; Xu D; Nan Y
    Medicine (Baltimore); 2023 Nov; 102(47):e36196. PubMed ID: 38013385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mechanism of Action of the Active Ingredients of
    Zou H; Niu Z; Tang Z; Cheng P; Yin Y; Luo G; Huang S
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the Mechanism of Zhibaidihuang Decoction against IgA Nephropathy Using Network Pharmacology and Molecular Docking Analyses.
    Deng X; Luo Y; Lu M; Guan T; Li Y; Guo X
    Tohoku J Exp Med; 2022 Dec; 259(1):37-47. PubMed ID: 36288951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of Chuanxiong Rhizoma-Paeoniae Radix Rubra drug pair on intervention of cerebral ischemia based on network pharmacology-molecular docking].
    Zhou HY; Sun RL; Ji QH; Tang DC; Gu JF
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(12):3007-3015. PubMed ID: 34467690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
    Fu S; Zhou Y; Hu C; Xu Z; Hou J
    BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.
    Guo MF; Dai YJ; Gao JR; Chen PJ
    J Diabetes Res; 2020; 2020():5947304. PubMed ID: 32215271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.
    Li Y; Wang L; Xu B; Zhao L; Li L; Xu K; Tang A; Zhou S; Song L; Zhang X; Zhan H
    J Diabetes Res; 2021; 2021():8891093. PubMed ID: 33628839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
    Dong Y; Zhao Q; Wang Y
    Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism.
    Guo X; Wu Y; Zhang C; Wu L; Qin L; Liu T
    Drug Des Devel Ther; 2021; 15():1577-1594. PubMed ID: 33883881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.